These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27673409)

  • 1. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
    Ma Y; Lu Y; Lu B
    Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis.
    Yang Y; Jiang Y; Wan Y; Zhang L; Qiu J; Zhou S; Cheng W
    Tumour Biol; 2016 Aug; 37(8):10633-41. PubMed ID: 26867765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Long Non-Coding RNAs in Ovarian Cancer.
    Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
    Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
    Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
    Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
    Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C
    Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA in glioma: signaling pathways.
    Shi J; Dong B; Cao J; Mao Y; Guan W; Peng Y; Wang S
    Oncotarget; 2017 Apr; 8(16):27582-27592. PubMed ID: 28187439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma.
    Jia LF; Wei SB; Gan YH; Guo Y; Gong K; Mitchelson K; Cheng J; Yu GY
    Int J Cancer; 2014 Nov; 135(10):2282-93. PubMed ID: 24343426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes virus microRNA expression and significance in serous ovarian cancer.
    Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
    PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer.
    Li J; Yu H; Xi M; Lu X
    J Ovarian Res; 2016 Aug; 9(1):49. PubMed ID: 27535740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer.
    De Leeneer K; Claes K
    Adv Exp Med Biol; 2015; 867():263-75. PubMed ID: 26530371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cross talk between long, non-coding RNAs and microRNAs in gastric cancer.
    Deng K; Wang H; Guo X; Xia J
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):111-6. PubMed ID: 26621794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA and Ovarian Cancer.
    Langhe R
    Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.